PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Amedisys, Inc. (AMED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0234361089
CUSIP023436108
SectorHealthcare
IndustryMedical Care Facilities

Highlights

Market Cap$2.95B
EPS-$0.30
PE Ratio1,170.13
PEG Ratio1.35
Revenue (TTM)$2.24B
Gross Profit (TTM)$453.98M
EBITDA (TTM)$216.91M
Year Range$73.10 - $96.44
Target Price$97.78
Short %8.90%
Short Ratio7.11

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Amedisys, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Amedisys, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
-0.37%
21.11%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Amedisys, Inc. had a return of -4.10% year-to-date (YTD) and 15.74% in the last 12 months. Over the past 10 years, Amedisys, Inc. had an annualized return of 20.87%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.


PeriodReturnBenchmark
Year-To-Date-4.10%6.30%
1 month-1.07%-3.13%
6 months-1.11%19.37%
1 year15.74%22.56%
5 years (annualized)-6.27%11.65%
10 years (annualized)20.87%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-0.83%-1.33%-0.92%
2023-0.37%-2.04%2.28%1.58%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of AMED is 77, placing it in the top 23% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of AMED is 7777
Amedisys, Inc.(AMED)
The Sharpe Ratio Rank of AMED is 7575Sharpe Ratio Rank
The Sortino Ratio Rank of AMED is 7878Sortino Ratio Rank
The Omega Ratio Rank of AMED is 8282Omega Ratio Rank
The Calmar Ratio Rank of AMED is 6060Calmar Ratio Rank
The Martin Ratio Rank of AMED is 8888Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Amedisys, Inc. (AMED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AMED
Sharpe ratio
The chart of Sharpe ratio for AMED, currently valued at 0.76, compared to the broader market-2.00-1.000.001.002.003.000.76
Sortino ratio
The chart of Sortino ratio for AMED, currently valued at 1.74, compared to the broader market-4.00-2.000.002.004.006.001.74
Omega ratio
The chart of Omega ratio for AMED, currently valued at 1.27, compared to the broader market0.501.001.501.27
Calmar ratio
The chart of Calmar ratio for AMED, currently valued at 0.21, compared to the broader market0.001.002.003.004.005.000.21
Martin ratio
The chart of Martin ratio for AMED, currently valued at 6.84, compared to the broader market0.0010.0020.0030.006.84
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current Amedisys, Inc. Sharpe ratio is 0.76. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.76
1.92
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Amedisys, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-70.98%
-3.50%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Amedisys, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Amedisys, Inc. was 91.22%, occurring on May 6, 1999. Recovery took 1101 trading sessions.

The current Amedisys, Inc. drawdown is 70.98%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.22%Jul 5, 1995845May 6, 19991101Nov 5, 20031946
-85.53%Aug 12, 2008871Jan 25, 20121565Apr 16, 20182436
-77.79%Jan 26, 2021544Mar 23, 2023
-34.29%Dec 14, 200548Feb 23, 2006299May 3, 2007347
-32.08%Feb 19, 202019Mar 16, 202021Apr 15, 202040

Volatility

Volatility Chart

The current Amedisys, Inc. volatility is 1.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


1.00%2.00%3.00%4.00%5.00%NovemberDecember2024FebruaryMarchApril
1.60%
3.58%
AMED (Amedisys, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Amedisys, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items